Medicover AB (publ) (MCVEF)
OTCMKTS · Delayed Price · Currency is USD
19.83
0.00 (0.00%)
Aug 28, 2025, 8:00 PM EDT
Medicover AB Market Cap
Medicover AB has a market cap or net worth of $4.37 billion as of August 29, 2025. Its market cap has increased by 69.01% in one year.
Market Cap
4.37B
Enterprise Value
5.98B
Revenue
2.65B
Ranking
n/a
PE Ratio
85.70
Stock Price
$19.83
Market Cap Chart
Since May 23, 2017, Medicover AB's market cap has increased from 1.01B to 4.37B, an increase of 334.19%. That is a compound annual growth rate of 19.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2025 | 4.37B | 67.35% |
| Dec 30, 2024 | 2.61B | 17.18% |
| Dec 29, 2023 | 2.23B | 11.46% |
| Dec 30, 2022 | 2.00B | -67.28% |
| Dec 30, 2021 | 6.11B | 105.74% |
| Dec 30, 2020 | 2.97B | 91.10% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |